NA
ID: ALA4463965
PubChem CID: 155530113
Max Phase: Preclinical
Molecular Formula: C36H52N2O5S
Molecular Weight: 624.89
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
ID: ALA4463965
PubChem CID: 155530113
Max Phase: Preclinical
Molecular Formula: C36H52N2O5S
Molecular Weight: 624.89
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)Cc5c([nH]c6ccc(S(N)(=O)=O)cc56)C(C)(C)[C@@H]4C(=O)C[C@]23C)O1
Standard InChI: InChI=1S/C36H52N2O5S/c1-31(2)13-9-14-36(8,43-31)23-12-15-34(6)28(23)25(39)17-27-33(5)18-22-21-16-20(44(37,41)42)10-11-24(21)38-30(22)32(3,4)29(33)26(40)19-35(27,34)7/h10-11,16,23,25,27-29,38-39H,9,12-15,17-19H2,1-8H3,(H2,37,41,42)/t23-,25+,27+,28-,29-,33+,34+,35+,36+/m0/s1
Standard InChI Key: PUTQQXGIOMZJQJ-ZUVMCECZSA-N
Molfile:
RDKit 2D 48 54 0 0 0 0 0 0 0 0999 V2000 25.3618 -23.7357 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 26.0717 -23.3312 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 25.3665 -22.9187 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 31.9654 -21.1149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 32.6794 -21.5276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 32.6783 -20.7044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 29.4519 -27.0953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 29.0474 -26.3854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 28.6343 -27.0927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 29.0511 -24.7427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 29.7605 -25.1555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 29.7570 -25.9768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 30.4632 -26.3902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 31.1732 -25.9828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 30.4701 -24.7476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 31.1767 -25.1663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 30.4755 -23.9244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 31.1936 -23.5184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 31.9030 -23.9415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 31.8910 -24.7640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 32.6697 -25.0283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 33.1646 -24.3691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 32.6891 -23.7001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 32.9573 -22.9237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 33.7645 -22.7631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 34.0290 -21.9937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 33.4900 -21.3713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 32.4147 -22.3067 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 28.3417 -25.9768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 28.3372 -25.1555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 27.5618 -26.2376 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 27.0737 -25.5751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 27.5568 -24.9104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 27.2240 -24.1633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 26.4085 -24.0797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 25.9267 -24.7493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 26.2621 -25.4937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 30.4586 -27.2115 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 29.7532 -24.3383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 31.1688 -24.3465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 31.8828 -25.5806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 33.4760 -23.4839 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 32.1387 -22.9185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 31.1895 -22.6998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 26.5513 -22.6715 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 32.4772 -24.5157 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 30.4631 -25.5641 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 28.9608 -25.7580 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 3 2 2 0 5 4 1 0 6 5 1 0 8 7 1 0 9 8 1 0 30 10 1 0 29 8 1 0 8 12 1 0 11 10 1 0 11 12 1 0 11 15 1 0 12 13 1 0 13 14 1 0 14 16 1 0 15 16 1 0 15 17 1 0 16 20 1 0 18 17 1 0 18 19 1 0 19 20 1 0 20 21 1 0 21 22 1 0 22 23 1 0 23 19 1 0 24 25 1 0 24 28 1 0 25 26 1 0 26 27 1 0 27 5 1 0 5 28 1 0 23 24 1 0 29 30 2 0 30 33 1 0 32 31 1 0 31 29 1 0 32 33 2 0 33 34 1 0 34 35 2 0 35 36 1 0 36 37 2 0 37 32 1 0 13 38 2 0 11 39 1 1 16 40 1 1 20 41 1 6 23 42 1 6 24 43 1 1 18 44 1 1 35 2 1 0 2 45 1 0 19 46 1 1 15 47 1 6 12 48 1 6 M END
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 624.89 | Molecular Weight (Monoisotopic): 624.3597 | AlogP: 6.40 | #Rotatable Bonds: 2 |
Polar Surface Area: 122.48 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.12 | CX Basic pKa: ┄ | CX LogP: 5.32 | CX LogD: 5.32 |
Aromatic Rings: 2 | Heavy Atoms: 44 | QED Weighted: 0.36 | Np Likeness Score: 1.71 |
1. Wu Q, Wang R, Shi Y, Li W, Li M, Chen P, Pan B, Wang Q, Li C, Wang J, Sun G, Sun X, Fu H.. (2020) Synthesis and biological evaluation of panaxatriol derivatives against myocardial ischemia/reperfusion injury in the rat., 185 [PMID:31655431] [10.1016/j.ejmech.2019.111729] |
Source(1):